Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis John P. BilezikianMishaela R. Rubin OriginalPaper Pages: 5 - 13
Ibandronate treatment for osteoporosis: Rationale, preclinical and clinical development of extended dosing regimens Solomon Epstein OriginalPaper Pages: 14 - 20
Review of adherence to medications for the treatment of osteoporosis Deborah T. GoldStuart Silverman OriginalPaper Pages: 21 - 27
Inhibition of RANKL as a treatment for osteoporosis: Preclinical and early clinical studies Michael R. McClung OriginalPaper Pages: 28 - 33
Strontium ranelate—Data on vertebral and nonvertebral fracture efficacy and safety: Mechanism of action David L. Kendler OriginalPaper Pages: 34 - 39